U
BGMD

UBS’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

UBS’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2K Sell
828
-142
-15% -$475 ﹤0.01% 10097
2014
Q2 		$4K Sell
970
-249
-20% -$1.18K ﹤0.01% 9763
2014
Q1 		$9K Buy
+1,219
New +$6.73K ﹤0.01% 9086
2013
Q4 		– Sell
-1,341
Closed -$5K – 11145
2013
Q3 		$5K Buy
1,341
+264
+25% +$1.11K ﹤0.01% 9493
2013
Q2 		$6K Buy
+1,077
New +$7.18K ﹤0.01% 9182

Other funds holding BGMD

FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS's BGMD Position: Q3 2014 in Review

UBS reduced its BG MEDICINE INC COM STK NEW (BGMD) stake by 15% in Q3 2014, selling an estimated $475 and leaving 828 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #10097.

UBS first reported a position in BGMD in Q2 2013 and has held it in 5 quarters since. The position peaked at $9K in Q1 2014. 27 funds tracked by Wall St. Rank hold BGMD as of Q3 2014.

  • UBS held 828 shares of BG MEDICINE INC COM STK NEW worth $2K as of Q3 2014.
  • UBS sold 142 BG MEDICINE INC COM STK NEW shares in Q3 2014, an estimated $475.
  • BG MEDICINE INC COM STK NEW made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10097 holding.
  • UBS first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and has held it in 5 quarters since.
  • UBS's BG MEDICINE INC COM STK NEW position peaked at $9K in Q1 2014.
  • 27 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.